XPO5 regulates ferroptosis via MITF-ACSL4 signaling to drive CRPC progression and serves as a druggable target

Cell Reports Medicine · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles